[1]
Stewart KD, Johnston JA, Matza LS, Curtis SE, Havel HA, Sweetana SA, Gelhorn HL. Preference for pharmaceutical formulation and treatment process attributes. Patient preference and adherence. 2016:10():1385-99. doi: 10.2147/PPA.S101821. Epub 2016 Jul 27
[PubMed PMID: 27528802]
[2]
Seddon G, Lounnas V, McGuire R, van den Bergh T, Bywater RP, Oliveira L, Vriend G. Drug design for ever, from hype to hope. Journal of computer-aided molecular design. 2012 Jan:26(1):137-50. doi: 10.1007/s10822-011-9519-9. Epub 2012 Jan 18
[PubMed PMID: 22252446]
[3]
Snell ES, Griffin JP. How many medicines are there? British medical journal (Clinical research ed.). 1985 Mar 9:290(6470):773-4
[PubMed PMID: 3918749]
[4]
Munos B. Lessons from 60 years of pharmaceutical innovation. Nature reviews. Drug discovery. 2009 Dec:8(12):959-68. doi: 10.1038/nrd2961. Epub
[PubMed PMID: 19949401]
[5]
Zhou SF, Zhong WZ. Drug Design and Discovery: Principles and Applications. Molecules (Basel, Switzerland). 2017 Feb 13:22(2):. doi: 10.3390/molecules22020279. Epub 2017 Feb 13
[PubMed PMID: 28208821]
[6]
Yang Y, Ye Z, Su Y, Zhao Q, Li X, Ouyang D. Deep learning for in vitro prediction of pharmaceutical formulations. Acta pharmaceutica Sinica. B. 2019 Jan:9(1):177-185. doi: 10.1016/j.apsb.2018.09.010. Epub 2018 Sep 28
[PubMed PMID: 30766789]
[7]
Zhang W, Zhao Q, Deng J, Hu Y, Wang Y, Ouyang D. Big data analysis of global advances in pharmaceutics and drug delivery 1980-2014. Drug discovery today. 2017 Aug:22(8):1201-1208. doi: 10.1016/j.drudis.2017.05.012. Epub 2017 Jun 13
[PubMed PMID: 28627386]
Level 3 (low-level) evidence
[8]
Thabet Y, Klingmann V, Breitkreutz J. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics. Journal of clinical pharmacology. 2018 Oct:58 Suppl 10():S26-S35. doi: 10.1002/jcph.1138. Epub
[PubMed PMID: 30248193]
[9]
Shah SM, Jain AS, Kaushik R, Nagarsenker MS, Nerurkar MJ. Preclinical formulations: insight, strategies, and practical considerations. AAPS PharmSciTech. 2014 Oct:15(5):1307-23. doi: 10.1208/s12249-014-0156-1. Epub 2014 Jun 12
[PubMed PMID: 24920522]
[10]
Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2001 Jan:7(1):33-7
[PubMed PMID: 11190902]
[11]
Morris LS, Schulz RM. Medication compliance: the patient's perspective. Clinical therapeutics. 1993 May-Jun:15(3):593-606
[PubMed PMID: 8364951]
Level 3 (low-level) evidence
[12]
Raue PJ, Schulberg HC, Heo M, Klimstra S, Bruce ML. Patients' depression treatment preferences and initiation, adherence, and outcome: a randomized primary care study. Psychiatric services (Washington, D.C.). 2009 Mar:60(3):337-43
[PubMed PMID: 19252046]
Level 1 (high-level) evidence
[13]
Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2004 Mar-Apr:7(2):204-15
[PubMed PMID: 15164810]
Level 3 (low-level) evidence
[14]
Cropp CD, Beall J, Buckner E, Wallis F, Barron A. Interprofessional Pharmacokinetics Simulation: Pharmacy and Nursing Students' Perceptions. Pharmacy (Basel, Switzerland). 2018 Jul 20:6(3):. doi: 10.3390/pharmacy6030070. Epub 2018 Jul 20
[PubMed PMID: 30036982]